AKO Capital Grifols SA - ADR - Level III

Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$18.3

Avg closing price
Price range
AKO Capital Portfolio Stock Details (GRFS)

15 AKO Capital Grifols SA Trades

The first Grifols SA trade was made in Q1 2017. Since then AKO Capital bought shares six more times and sold shares on eight occasions. The investor completely sold their stake between Q2 2020 and Q3 2020.

Avg closing price
Price range
Sold -12.3 Million shares Q3 2020
Avg closing price $17.66
Price range $15.40 - $20.16
Sold 7.3% shares (-969 Thousand shares) Q2 2020
Avg closing price $19.84
Price range $18.24 - $21.45
Increased shares by 6.7% (+835 Thousand shares) Q1 2020
Avg closing price $22.40
Price range $16.28 - $25.63
Increased shares by 2.0% (+247 Thousand shares) Q4 2019
Avg closing price $21.79
Price range $19.57 - $23.52
Sold 3.2% shares (-403 Thousand shares) Q3 2019
Avg closing price $21.46
Price range $19.85 - $22.76
Increased shares by 5.5% (+654 Thousand shares) Q2 2019
Avg closing price $19.07
Price range $17.59 - $21.10
Sold 3.1% shares (-375 Thousand shares) Q1 2019
Avg closing price $19.11
Price range $18.01 - $20.11
Increased shares by 24.7% (+2.44 Million shares) Q4 2018
Avg closing price $19.89
Price range $17.44 - $21.53
Sold 8.5% shares (-913 Thousand shares) Q3 2018
Avg closing price $21.11
Price range $19.97 - $21.96
Sold 7.6% shares (-890 Thousand shares) Q2 2018
Avg closing price $21.82
Price range $20.16 - $24.68
Increased shares by 2.6% (+297 Thousand shares) Q1 2018
Avg closing price $22.78
Price range $20.31 - $24.95
Sold 1.0% shares (-112 Thousand shares) Q4 2017
Avg closing price $22.21
Price range $20.99 - $23.89
Sold 7.1% shares (-877 Thousand shares) Q3 2017
Avg closing price $20.75
Price range $20.06 - $21.89
Increased shares by 5.7% (+667 Thousand shares) Q2 2017
Avg closing price $20.95
Price range $18.86 - $22.58
New holding (+11.7 Million shares) Q1 2017
Avg closing price $17.35
Price range $16.10 - $19.03

News about Grifols SA - ADR - Level III and AKO Capital

Troubled Spanish pharma company Grifols says it may go private for $6 billion

Troubled Spanish pharma company Grifols says it may go private for $6 billion

Shares of Grifols were halted on Monday, following news the Spanish blood plasma pharmaceutical company may go private in a deal with Canadian investment man...

marketwatch.com marketwatch.com, 10 months ago
Capital World Investors Boosts Stock Position in Grifols, S.A. (NASDAQ:GRFS)

Capital World Investors Boosts Stock Position in Grifols, S.A. (NASDAQ:GRFS)

… Exchange Commission. The institutional investor owned 19,515,756 … investors have also bought and sold shares of the business. Brandes Investment … quarter...

EIN News Investing EIN News Investing, over 1 year ago
United Capital Financial Advisers LLC Sells 512,630 Shares of Grifols, S.A. (NASDAQ:GRFS)

United Capital Financial Advisers LLC Sells 512,630 Shares of Grifols, S.A. (NASDAQ:GRFS)

United Capital Financial Advisers LLC lessened its holdings in Grifols, S.A. (NASDAQ:GRFS) by 95.4% in the second quarter, HoldingsChannel reports. The fund ...

Dakota Financial News Dakota Financial News, over 3 years ago
Velanne Asset Management Ltd Buys Grifols SA, Burford Capital, Raytheon Technologies Corp, ...

Velanne Asset Management Ltd Buys Grifols SA, Burford Capital, Raytheon Technologies Corp, ...

Related Stocks: RTX , VST , HII , JNJ , DIS , BSIG , GRFS , BUR ,

GuruFocus GuruFocus, over 3 years ago
Never miss a trade

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!

To improve your user experience we use cookies.